BEUDAMED
    10,000 results · 50ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Aptima HCV Quant Dx Assay

    Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·ELECSYS ANTI-HCV IMMUNOASSAY & ELECSYS PRECICONTROL ANTI-HCV FOR USE ON THE ROCHE COBAS E 601 IMMUNOASSAY ANALYZER

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·Abbott RealTime HCV Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS AMPLIPREP/COBAS TAQMAN HCV TEST, V2.0

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS AmpliPrep/COBAS TaqMan CMV Test

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS AMPLIPREP / COBAS TAQMAN HCV TEST

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·Alinity m CMV Assay

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS AMPLICOR HCV TEST, V2.0, COBAS AMPLIPREP/COBAS AMPLICOR HCV TEST, VERSION 2.0

    System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

    FDA Pre-Market Approval
    FDA Class 2 ·API 3600S ANTIMICROBIAL SUSCEPTIBILITY SYSTEM

    Susceptibility Test Cards, Antimicrobial

    FDA Pre-Market Approval
    FDA Class 2 ·VITEK GRAM NEGATIVE SUSCEPTIBILITY CARD-AMPICILLIN/SULBACTAM

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·AMPLICOR HEPATITIS C VIRUS (HCV) TEST, VERSION 2.0

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·Alinity m CMV

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

    Susceptibility Test Cards, Antimicrobial

    FDA Pre-Market Approval
    FDA Class 2 ·AMS GRAM-NEGITIVE ANTIMICROBIAL SUSCEPT. PANELS

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·COBAS AMPLIPREP/COBAS TAQMAN CMV TEST

    Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·ARCHITECT ANTI-HCV

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·Cobas CMV

    Susceptibility Test Cards, Antimicrobial

    FDA Pre-Market Approval
    FDA Class 2 ·AMS GRAM-NEGITIVE ANTIMICROBIAL SUSCEPT. PANELS

    Susceptibility Test Cards, Antimicrobial

    FDA Pre-Market Approval
    FDA Class 2 ·VITEK 2 GRAM NEGATIVE AST FOR CEFOTETAN

    Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

    FDA Pre-Market Approval
    FDA Class 2 ·AMPLICOR HEPATITIS C VIRUS (HCV) TEST VERSION 2.0